The complex photophysics of the wild-type green fluorescent protein (GFP), one of the most popular fluorescent probes in biology, has been extensively documented in literature. The excited-state ...

Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies ...

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse ...

A research team has discovered that a specific group of neurons in the amygdala, a brain region involved in emotion ...

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by ...

They found that levels of the GFP protein decreased to nearly undetectable levels once ... Romerio says the new findings could lead to gene therapies that permanently enhance production of AST in the ...

The autocatalytic maturation of the chromophore in green fluorescent protein (GFP) was thought to require the precise positioning of the side chains surrounding it in the core of the protein, many of ...

Shares of Sarepta Therapeutics closed down as much as 42% to hit a nine-year low of $18.30 on Monday after a second death of a male teenage patient who had received its gene therapy, Elevidys ...

WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported ...

A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile. | A second ...